Table 3 of Davoudi, Mol Vis 2018; 24:59-74.
Gene | Chr | SNP | Ref/Alternate Allele | Ref Allele Frequency Cases (n=45) | Ref Allele Frequency Controls (n=32) | OR | 95% CI | Pcorr |
---|---|---|---|---|---|---|---|---|
CFH Y402H | 1 | rs1061170 | C/T | 0.34 | 0.37 | 0.87 | 0.45–1.71 | 0.85 |
IL23R | 1 | rs11209026 | A/G | 0.07 | 0.04 | 1.52 | 0.36–6.34 | 0.48 |
IL23R | 1 | rs11465804 | G/T | 0.07 | 0.06 | 1.07 | 0.29–3.96 | 0.85 |
IL23R | 1 | rs7517847 | G/T | 0.38 | 0.29 | 1.51 | 0.48–4.78 | 0.47 |
TGF-β2 | 1 | rs1891467 | G/A | 0.31 | 0.23 | 1.50 | 0.72–3.12 | 0.34 |
CCR 5 | 3 | rs1799987 | A/G | 0.51 | 0.45 | 1.26 | 0.66–2.40 | 0.85 |
BTNL2 | 6 | rs9268480 | T/C | 0.31 | 0.22 | 1.63 | 0.77–3.45 | 0.17 |
BTNL2 | 6 | rs9268482 | T/A | 0.31 | 0.22 | 1.63 | 0.77–3.45 | 0.17 |
HLA- DQA1 | 6 | rs17843604 | T/C | 0.49 | 0.48 | 1.02 | 0.54–1.93 | 1.00 |
HLA- DRA | 6 | rs7192 | T/G | 0.35 | 0.47 | 0.61 | 0.32–1.18 | 0.17 |
HLA- DRA | 6 | rs7194 | G/A | 0.35 | 0.47 | 0.61 | 0.32–1.18 | 0.17 |
HLA- DRB1 | 6 | rs615672 | C/G | 0.40 | 0.48 | 0.71 | 0.37–1.35 | 0.34 |
HLA- DRB5 | 6 | rs17203612 | T/A | 0.41 | 0.25 | 2.06 | 1.01–4.19 | 0.07 |
HSP-70/Hom | 6 | rs2075800 | T/C | 0.30 | 0.35 | 0.76 | 0.38–1.51 | 0.50 |
HSP-70/Hom | 6 | rs1043620 | T/C | 0.03 | 0.08 | 0.31 | 0.05–1.65 | 0.24 |
LTA | 6 | rs909253 | G/A | 0.50 | 0.36 | 1.78 | 0.92–3.44 | 0.15 |
NOTCH4 | 6 | rs715299 | G/T | 0.38 | 0.31 | 1.37 | 0.69–2.71 | 0.40 |
RAB23 | 6 | rs1040461 | T/C | 0.02 | 0.00* | N/A | N/A | 0.01 |
TNF-α | 6 | rs1800629 | A/G | 0.16 | 0.17 | 0.94 | 0.39–2.23 | 1.00 |
TLR4 | 9 | rs4986790 | G/A | 0.02 | 0.07 | 0.31 | 0.05–1.43 | 0.10 |
ANXA11 | 10 | rs2789679 | T/A | 0.31 | 0.41 | 0.66 | 0.34–1.29 | 0.18 |
ANXA11 | 10 | rs2573346 | A/G | 0.33 | 0.41 | 0.71 | 0.36–1.38 | 0.27 |
ANXA11 | 10 | rs1049550 | A/G | 0.34 | 0.41 | 0.74 | 0.38–1.45 | 0.35 |
ANXA11 | 10 | rs61860052 | A/C | 0.13 | 0.03 | 4.77 | 1.03–22.11 | 0.02 |
ANXA11 and PLAC9 | 10 | rs1953600 | T/C | 0.32 | 0.41 | 0.71 | 0.36–1.38 | 0.26 |
C10ORF67/10p12.2 | 10 | rs1398024 | T/G | 0.21 | 0.20 | 1.05 | 0.47–2.32 | 1.00 |
IL2RA | 10 | rs12722489 | T/C | 0.13 | 0.08 | 1.73 | 0.57–5.26 | 0.31 |
CDCC88B | 11 | rs671976 | G/A | 0.50 | 0.50 | 1.00 | 0.52–1.91 | 1.00 |
CDCC88B | 11 | rs479777 | C/T | 0.26 | 0.28 | 0.88 | 0.42–1.82 | 0.86 |
OS9 | 12 | rs11172300 | T/C | 0.36 | 0.36 | 1.00 | 0.51–1.97 | 0.86 |
OS9 | 12 | rs701007 | A/C | 0.40 | 0.42 | 0.91 | 0.48–1.75 | 0.86 |
OS9 | 12 | rs799265 | G/A | 0.43 | 0.42 | 1.05 | 0.55–2.00 | 1.00 |
TGF-β3 | 14 | rs3917200 | G/A | 0.17 | 0.09 | 2.04 | 0.74–5.60 | 0.31 |
TGF-β3 | 14 | rs3917165 | T/C | 0.12 | 0.08 | 1.55 | 0.50–4.79 | 0.59 |
HERC2 | 15 | rs916977 | T/C | 0.33 | 0.30 | 1.14 | 0.57–2.42 | 0.85 |